Related Experiment Video

Updated: Dec 30, 2025

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models
03:42

Author Spotlight: Validating Cancer Therapy Responses with Desmoplastic Spheroid Models

Published on: September 27, 2024

1.9K

GSK-3: An important kinase in colon and pancreatic cancers

Roberto J Vidri1, Timothy L Fitzgerald1

  • 1Division of Surgical Oncology, Tufts University School of Medicine-Maine Medical Center, Portland, ME, United States of America.

Biochimica Et Biophysica Acta. Molecular Cell Research
|January 29, 2020
PubMed

Insights

Glycogen synthase kinase 3 (GSK-3) is crucial in pancreatic and colon cancers. Targeting GSK-3 may offer promising therapies for these cancers, but further research into downstream effects is needed.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Glycogen synthase kinase 3 (GSK-3) is a key enzyme in glycogen synthesis and cellular metabolism.
  • GSK-3 and β-catenin are implicated in the neoplastic transformation and tumorigenesis of human cells.
  • Pancreatic cancer has dismal survival rates due to resistance and metastasis, while colon cancer incidence is rising, particularly in younger populations.

Purpose of the Study:

  • To explore the role of GSK-3 in pancreatic and colon cancers.
  • To evaluate the potential of GSK-3 as a therapeutic target in these malignancies.

Main Methods:

  • This review synthesizes existing research on GSK-3's function in cancer.
  • Literature analysis focusing on GSK-3's involvement in Wnt signaling and tumorigenesis.
  • Examination of current treatment outcomes and future therapeutic strategies.

Main Results:

  • GSK-3 plays a fundamental role in cellular metabolism and is involved in the neoplastic transformation.
  • While pancreatic cancer outcomes remain poor, colon cancer survival is often good, though incidence is increasing.
  • Targeting GSK-3 presents a potential avenue for novel cancer therapies.

Conclusions:

  • GSK-3 is a significant factor in both pancreatic and colon cancer development.
  • Targeted therapies involving GSK-3 may offer future treatment options for these cancers.
  • A comprehensive understanding of GSK-3's downstream effects is essential for successful therapeutic application.
Keywords:
CancerColonGSK-3Pancreasβ-Catenin

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.5K
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K